[ Price : $8.95]
FDAs Office of the Commissioner says it will hear Ethicons appeal of the CDRH decision that the companys Sedasys PMA is not approv...[ Price : $8.95]
A new report by Booz Hamilton shows that FDA is slow to review the final study reports required by post-marketing requirements and...[ Price : $8.95]
Echo Therapeutics files a 510(k) with FDA for the Prelude SkinPrep System and 4% lidocaine cream for transdermal drug delivery.[ Price : $8.95]
Dendreon submits a BLA supplement to increase the manufacturing capacity for Provenge (sipuleucel-T) at its Morris Plains, NJ manu...[ Price : $8.95]
FDA tells Bionovo that it supports the companys overall clinical development plan for Menerba to treat menopausal hot flashes.[ Price : $8.95]
A DC Appeals Court ruling dismisses an Actavis claim that FDA should not enforce five years of marketing exclusivity for Shires Vy...[ Price : $8.95]
FDA approves a PolyMedix IND for PMX-30063, a synthetic defensin-mimetic antibiotic to initiate a Phase 1 clinical trial in the U....[ Price : $8.95]
AstraZeneca CEO David Brennan tells the Reuters Health Summit that significant cuts in taxpayer funding for FDA could mean slower ...